| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/23/2014 | US20140025300 Moisture measuring apparatus and computer-readable medium |
| 01/23/2014 | US20140025000 Systems and Methods For Monitoring Health and Delivering Drugs Transdermally |
| 01/23/2014 | US20140024811 Cancer detection |
| 01/23/2014 | US20140024807 Lenalidomide and Thalidomide Immunoassays |
| 01/23/2014 | US20140024792 Screening processes, conducting polymers, and electrochromic devices based on diffusional gradients |
| 01/23/2014 | US20140024725 Modulators for trpa1 for the treatment of rosacea |
| 01/23/2014 | US20140024700 Blood-borne mirnas as surrogate markers of drug efficacy for cardiac conditions |
| 01/23/2014 | US20140024686 Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles |
| 01/23/2014 | US20140024648 New pyridazinone and pyridone compounds |
| 01/23/2014 | US20140024623 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment |
| 01/23/2014 | US20140024558 Method of Treatment |
| 01/23/2014 | US20140024556 Co-coupling to control reactivity of reagents in immunoassays |
| 01/23/2014 | US20140024555 Method of identifying soluble proteins and soluble protein complexes |
| 01/23/2014 | US20140024553 Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| 01/23/2014 | US20140024552 Compositions and methods for diagnosing ovarian cancer |
| 01/23/2014 | US20140024550 Solid Support Assay Systems and Methods Utilizing Non-Standard Bases |
| 01/23/2014 | US20140024549 Devices and methods for detecting human metapneumovirus |
| 01/23/2014 | US20140024548 Drug selection for malignant cancer therapy using antibody-based arrays |
| 01/23/2014 | US20140024125 Study of polymer molecules and conformations with a nanopore |
| 01/23/2014 | US20140024124 Labeling agent for analyzing post-translational modifications of serine and threonine |
| 01/23/2014 | US20140024073 Bio-mems for downhole fluid analysis |
| 01/23/2014 | US20140024072 Sample analyzer, sample information processing apparatus, and sample analysis method |
| 01/23/2014 | US20140024071 Photo-uncaging-assisted evaluation of large-scale synaptic reorganization of brain circuits |
| 01/23/2014 | US20140024068 Multicellular system and method for multiparametric analysis |
| 01/23/2014 | US20140024066 Animal model having photo-activatable mitochondria |
| 01/23/2014 | US20140024065 Ex vivo method for determining potential glp-2 receptor modulators |
| 01/23/2014 | US20140024060 Use of hydrogels for biosensors having elevated sensitivity |
| 01/23/2014 | US20140024059 Apparatus and methods for analyzing fluid variables |
| 01/23/2014 | US20140024058 Coelenterazine analogs and manufacturing method thereof |
| 01/23/2014 | US20140024057 Systems and methods for detecting animal pregnancy |
| 01/23/2014 | US20140024056 Surrogates of post-translationally modified proteins and uses thereof |
| 01/23/2014 | US20140024055 Antihuman baff antibody |
| 01/23/2014 | US20140024054 Antibody, kit and method for determining amyloid peptides |
| 01/23/2014 | US20140024053 Methods, kits and devices for detecting bii-spectrin, and breakdown products thereof, as biomarkers for the diagnosis of neural injury |
| 01/23/2014 | US20140024052 Sequence-specific extraction and analysis of dna-bound proteins |
| 01/23/2014 | US20140024051 Methods and Compositions for Biomarkers of Fatigue |
| 01/23/2014 | US20140024050 Antibodies which detect pivkaii and methods of use thereof |
| 01/23/2014 | US20140024048 Protein |
| 01/23/2014 | US20140024046 Exosomal Biomarkers for Cardiovasular Events |
| 01/23/2014 | US20140024045 Use of micropatterned soft substrate for measuring of cell traction forces |
| 01/23/2014 | US20140024044 Cell cycle measuring method based on an electrochemical method |
| 01/23/2014 | US20140024043 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1 |
| 01/23/2014 | US20140024042 Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma |
| 01/23/2014 | US20140024041 Soft substrate for cell culture and process for preparing the same |
| 01/23/2014 | US20140024030 Preselection of subjects for therapeutic treatment with oxygen sensitive agents based in hypoxic status |
| 01/23/2014 | US20140024026 Metallic nanoparticle synthesis with carbohydrate capping agent |
| 01/23/2014 | US20140024019 Methods and Means for Monitoring Disruption of Tissue Homeostasis in the Total Body |
| 01/23/2014 | US20140024017 IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS |
| 01/23/2014 | US20140024016 Lateral flow assays using two dimensional features |
| 01/23/2014 | US20140024013 Isolation, Cloning and Characterization of New Adeno-Associated Virus (AAV) Serotypes |
| 01/23/2014 | US20140024010 Method for producing artificial skin model, and artificial skin model |
| 01/23/2014 | US20140023698 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents |
| 01/23/2014 | US20140023686 Soluble icam-1 as biomarker for prediction of therapeutic response |
| 01/23/2014 | US20140023662 Non-antagonistic egfr-binding molecules and immunoconjugates thereof |
| 01/23/2014 | US20140023657 In vitro method for identifying compounds for cancer therapy |
| 01/23/2014 | US20140023656 Pharmaceutical composition for treatment and prevention of th3 march-related diseases |
| 01/23/2014 | US20140023652 Methods and compositions based on shiga toxin type 1 protein |
| 01/23/2014 | US20140023640 Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapy |
| 01/23/2014 | US20140023639 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/23/2014 | US20140023624 Decellularized liver transplantation composition and methods |
| 01/23/2014 | US20140023622 Brown Fat Cell Compositions and Methods |
| 01/23/2014 | US20140023619 Viral vector targeting cancer stem cells |
| 01/23/2014 | US20140023584 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same |
| 01/23/2014 | US20140023557 Electronic nose device |
| 01/23/2014 | US20140023111 Device for measuring relative humidity and temperature of the air in a diphasic medium |
| 01/23/2014 | US20140020462 Method and apparatus for analyzing multiphase fluid flow using a multivariate optical element calculation device |
| 01/23/2014 | US20140020460 Methods and systems for monitoring engine oil temperature of an operating engine |
| 01/23/2014 | US20140020456 Method For Preparing Petroleum Based Samples For Analysis of Elemental and Isotopic Species |
| 01/23/2014 | US20140020452 Fuel property sensor |
| 01/23/2014 | US20140020451 Fuel property sensor |
| 01/23/2014 | US20140020448 Combustible gas detecting device |
| 01/23/2014 | US20140020446 Gas sensor |
| 01/23/2014 | DE102012216514A1 Verfahren zur statistischen Qualitätssicherung bei einer Untersuchung von Stahlprodukten innerhalb einer Stahlklasse Method for statistical quality control in an investigation of steel products within a steel grade |
| 01/23/2014 | DE102012212865A1 Dosieranlage zur Behandlung von Wasser und Verfahren zu deren Betrieb Dosing system for treatment of water, and method for its operation |
| 01/23/2014 | CA2876787A1 Inhibitors of the cd95 signaling pathway for treatment of mds |
| 01/23/2014 | CA2876303A1 Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder |
| 01/22/2014 | EP2687854A1 Test kit for the quantitative determination of narcotic drugs |
| 01/22/2014 | EP2687853A1 Combination for early exclusion of acute myocardial infarction |
| 01/22/2014 | EP2687852A1 Method for diagnosing and treating chronic fatigue syndrome |
| 01/22/2014 | EP2687851A1 Method for increasing implantation success in assisted fertilization |
| 01/22/2014 | EP2687850A1 Methods of stratifying for respiratory support therapy |
| 01/22/2014 | EP2687849A1 A process for providing an optimized immune therapy composition |
| 01/22/2014 | EP2687848A1 Status of tuberculosis infection in an individual |
| 01/22/2014 | EP2687847A1 Probe for analyzing biological tissue and method for utilizing same |
| 01/22/2014 | EP2687846A1 Device for rapid determination of disease-associated thiol compounds |
| 01/22/2014 | EP2687845A1 Fucose as a biomarker for gut immunity |
| 01/22/2014 | EP2687844A2 Air quality monitoring device |
| 01/22/2014 | EP2687836A1 Nitrogen oxide concentration measurement device |
| 01/22/2014 | EP2687595A1 Method for purifying transgenic factor VII |
| 01/22/2014 | EP2687264A1 Macrophage Activating Factor for treatment of endometriosis |
| 01/22/2014 | EP2687231A1 Composition for treatment and diagnosis of pancreatic cancer |
| 01/22/2014 | EP2686689A2 Methods predicting risk of an adverse clinical outcome |
| 01/22/2014 | EP2686688A2 Systems and compositions for diagnosing barrett's esophagus and methods of using the same |
| 01/22/2014 | EP2686687A2 A method of screening anti-tubercular compounds |
| 01/22/2014 | EP2686686A1 Method for characterising the origin and/or condition of diseased or healthy cells, and uses thereof in biology |
| 01/22/2014 | EP2686685A1 Whole proteome tiling microarrays |
| 01/22/2014 | EP2686684A1 Multisignal labeling reagents and processes and uses therefor |
| 01/22/2014 | EP2686683A2 Metal-enhanced photoluminescence from carbon nanodots |
| 01/22/2014 | EP2686681A1 Diagnostic biomarker to predict women at risk for preterm delivery |
| 01/22/2014 | EP2686680A1 Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules |